Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Transplantation|March 14, 2007
Sparing effect by montelukast treatment for chronic graft versus host disease: a pilot studyReuven Or, Benjamin Gesundheit, Igor Resnick, et al.
Haematologica|August 5, 2005
Successful engraftment following allogeneic stem cell transplantation in very high-risk patients with busulfan as a single agentMenachem Bitan, Reuven Or, Michael Y Shapira, et al.
Molecular Immunology|April 20, 2010
Heparanase upregulates Th2 cytokines, ameliorating experimental autoimmune encephalitisMenachem Bitan, Lola Weiss, Israel Reibstein, et al.
Quintessence International (Berlin, Germany : 1985)|December 25, 2008
Oral effects of nonmyeloablative stem cell transplantation: a prospective observational studySharon Elad, Michael Y Shapira, Sandre McNeal, et al.
Frontiers in Pharmacology|February 21, 2022
The Association Between Proton Pump Inhibitors and COVID-19 is Confounded by Hyperglycemia in a Population-Based StudyAsher Shafrir, Ariel A Benson, Lior H Katz, et al.
Experimental Hematology|February 2, 2002
Heparanase expression in human leukemias is restricted to acute myeloid leukemiasMenachem Bitan, Aaron Polliack, Gabriella Zecchina, et al.
Endocrine-Related Cancer|May 27, 2006
The role of imatinib mesylate (Glivec) for treatment of patients with malignant endocrine tumors positive for c-kit or PDGF-RDavid J Gross, Gabriel Munter, Menachem Bitan, et al.
Clinical Transplantation|November 2, 2004
Spinal epidural lipomatosis following haploidentical allogeneic bone marrow transplantation for non-Hodgkin lymphomaIgor B Resnick, John M Gomori, David Kiselgoff, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 18, 2008
ABO incompatibility is associated with increased non-relapse and GVHD related mortality in patients with malignancies treated with a reduced intensity regimen: a single center experience of 221 patientsIgor B Resnick, Panagiotis D Tsirigotis, Michael Y Shapira, et al.
Pediatric Transplantation|March 19, 2016
Combined plerixafor and granulocyte colony-stimulating factor for harvesting high-dose hematopoietic stem cells: Possible niche for plerixafor use in pediatric patientsMenachem Bitan, Rinat Eshel, Efraim Sadot, et al.
Pageof 4